Literature DB >> 6734

A possible metabolic explanation for drug-induced phospholipidosis.

R H Michell, D Allan, M Bowley, D N Brindley.   

Abstract

Mesh:

Substances:

Year:  1976        PMID: 6734     DOI: 10.1111/j.2042-7158.1976.tb04172.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  6 in total

1.  The effects of amphiphilic cationic drugs and inorganic cations on the activity of phosphatidate phosphohydrolase.

Authors:  M Bowley; J Cooling; S L Burditt; D N Brindley
Journal:  Biochem J       Date:  1977-09-01       Impact factor: 3.857

2.  Factors controlling the activities of phosphatidate phosphohydrolase and phosphatidate cytidylyltransferase. The effects of chlorpromazine, demethylimipramine, cinchocaine, norfenfluramine, mepyramine and magnesium ions.

Authors:  R G Sturton; D N Brindley
Journal:  Biochem J       Date:  1977-01-15       Impact factor: 3.857

3.  Relationship between lipid composition and drug metabolizing capacity of human liver.

Authors:  M J Savolainen; A J Arranto; I E Hassinen; P V Luoma; R O Pelkonen; E A Sotaniemi
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Effects of phenobarbital upon triacylglycerol metabolism in the rabbit.

Authors:  D M Goldberg; M W Roomi; A Yu; D A Roncari
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

5.  Triacylglycerol metabolism in the phenobarbital-treated rat.

Authors:  D M Goldberg; M W Roomi; A Yu; D A Roncari
Journal:  Biochem J       Date:  1981-04-15       Impact factor: 3.857

Review 6.  Pulmonary and generalized lysosomal storage induced by amphiphilic drugs.

Authors:  Z Hruban
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.